nasopharyngeal carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Treatment-naive patients with nasopharyngeal carcinoma of lymph nodes matastasis stage 1 or 2 confirmed by histopathology; 2. Radical radiotherapy, target area including nasopharynx and cervical lymphatic drainage area 3. Aged 18-75 years; 4. ECOG scores of 0 to 2; 5. Informed consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Severe dysfunction in heart, liver, kidney, central nerve systems or psychological disorders; 2. Allergic histories; 3. Communication disorders, non-cooperators; 4. Having received radiotherapy, laser or cryotherapy in the skin of irradiation area; 5. Skin rash, breakage, infection in the skin of irradiation area; 6. Using targeted drugs such as Cetuximab; 7. Pregnancy of planning a pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of moist desquamation;Severity of moist desquamation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Onset time of acute radioactive dermatitis;Healing time of acute radioactive dermatitis;Onset time of Moist desquamation;Onset Healing time of Moist desquamation;Chief complaints of patients;Costs of skin care during the treatment;The quality of life;Frequencies of long-term disorders in cervical activities; | — |
Countries
China
Contacts
The affiliated Drum Tower Hospital of Nanjing University Medical School